JP2010519930A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010519930A5 JP2010519930A5 JP2009552704A JP2009552704A JP2010519930A5 JP 2010519930 A5 JP2010519930 A5 JP 2010519930A5 JP 2009552704 A JP2009552704 A JP 2009552704A JP 2009552704 A JP2009552704 A JP 2009552704A JP 2010519930 A5 JP2010519930 A5 JP 2010519930A5
- Authority
- JP
- Japan
- Prior art keywords
- host cell
- signal peptide
- golgi
- catalytic domain
- recombinant glycoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims description 39
- 102000003886 Glycoproteins Human genes 0.000 claims description 23
- 108090000288 Glycoproteins Proteins 0.000 claims description 23
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 18
- 210000002288 golgi apparatus Anatomy 0.000 claims description 17
- 230000003197 catalytic effect Effects 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 15
- 102100021771 Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase Human genes 0.000 claims description 6
- 108010009689 mannosyl-oligosaccharide 1,2-alpha-mannosidase Proteins 0.000 claims description 6
- 108090000992 Transferases Proteins 0.000 claims description 5
- 102000004357 Transferases Human genes 0.000 claims description 5
- 108010070113 alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I Proteins 0.000 claims description 5
- 229930182830 galactose Natural products 0.000 claims description 5
- 108010083819 mannosyl-oligosaccharide 1,3 - 1,6-alpha-mannosidase Proteins 0.000 claims description 5
- 101000918297 Caenorhabditis elegans Exostosin-2 homolog Proteins 0.000 claims description 4
- 102000003838 Sialyltransferases Human genes 0.000 claims description 4
- 108090000141 Sialyltransferases Proteins 0.000 claims description 4
- 108010039255 alpha 1,6-mannosyltransferase Proteins 0.000 claims description 2
- GRHWEVYJIHXESA-HBHDJDHDSA-N beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)O2)O)[C@@H](CO)O1 GRHWEVYJIHXESA-HBHDJDHDSA-N 0.000 claims description 2
- WYUKJASPBYYQRJ-VSJOFRJTSA-N beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->3)-[beta-D-GlcpNAc-(1->2)-alpha-D-Manp-(1->6)]-beta-D-Manp-(1->4)-beta-GlcpNAc-(1->4)-beta-D-GlcpNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)NC(C)=O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)NC(C)=O)O2)O)[C@@H](CO)O1 WYUKJASPBYYQRJ-VSJOFRJTSA-N 0.000 claims description 2
- 108020001507 fusion proteins Proteins 0.000 claims 4
- 102000037865 fusion proteins Human genes 0.000 claims 4
- 230000037361 pathway Effects 0.000 claims 4
- 102000004190 Enzymes Human genes 0.000 claims 3
- 108090000790 Enzymes Proteins 0.000 claims 3
- 230000033581 fucosylation Effects 0.000 claims 3
- 108091026890 Coding region Proteins 0.000 claims 2
- 108020004414 DNA Proteins 0.000 claims 2
- 101000830049 Drosophila melanogaster GDP-mannose 4,6 dehydratase Proteins 0.000 claims 2
- 101710203794 GDP-fucose transporter Proteins 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 230000008685 targeting Effects 0.000 claims 2
- 241001466460 Alveolata Species 0.000 claims 1
- 108020004705 Codon Proteins 0.000 claims 1
- 101001030665 Dictyostelium discoideum GDP-L-fucose synthase Proteins 0.000 claims 1
- 102000006471 Fucosyltransferases Human genes 0.000 claims 1
- 108010019236 Fucosyltransferases Proteins 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000235058 Komagataella pastoris Species 0.000 claims 1
- 241000243190 Microsporidia Species 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 241001466451 Stramenopiles Species 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 108020001778 catalytic domains Proteins 0.000 claims 1
- 238000005457 optimization Methods 0.000 claims 1
- HNQXDLYBFNWFEE-VHZSLYHRSA-N n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5r)-2-acetamido-5-[(2r,3s,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-1-oxo-4-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] Chemical compound O([C@H]([C@H](C=O)NC(=O)C)[C@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H](CO[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1[C@H]([C@@H](O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O HNQXDLYBFNWFEE-VHZSLYHRSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90534507P | 2007-03-07 | 2007-03-07 | |
| PCT/US2008/002787 WO2008112092A2 (en) | 2007-03-07 | 2008-03-03 | Production of glycoproteins with modified fucosylation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010519930A JP2010519930A (ja) | 2010-06-10 |
| JP2010519930A5 true JP2010519930A5 (enExample) | 2013-11-14 |
Family
ID=39639063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009552704A Pending JP2010519930A (ja) | 2007-03-07 | 2008-03-03 | 糖タンパク質の修飾フコシル化を用いる産生 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100028951A1 (enExample) |
| EP (1) | EP2134834B1 (enExample) |
| JP (1) | JP2010519930A (enExample) |
| KR (1) | KR20090130029A (enExample) |
| CN (1) | CN101679934B (enExample) |
| AU (1) | AU2008227024A1 (enExample) |
| CA (1) | CA2679732A1 (enExample) |
| RU (1) | RU2479629C2 (enExample) |
| SG (1) | SG187521A1 (enExample) |
| WO (1) | WO2008112092A2 (enExample) |
| ZA (1) | ZA200905728B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ593448A (en) | 2008-12-19 | 2012-06-29 | Jennewein Biotechnologie Gmbh | Synthesis of fucosylated compounds |
| PL2438171T3 (pl) | 2009-06-02 | 2015-04-30 | Regeneron Pharma | Komórki z niedoborem fukozylacji |
| CN102858949B (zh) | 2010-02-24 | 2016-07-06 | 默沙东公司 | 用于增加在巴氏毕赤酵母中生产的治疗性糖蛋白上的n-糖基化位点占据的方法 |
| TW201209160A (en) * | 2010-04-27 | 2012-03-01 | Lonza Ag | Improved glycosylation of proteins in host cells |
| EP2678440B1 (en) | 2011-02-25 | 2018-05-23 | Merck Sharp & Dohme Corp. | Yeast strain for the production of proteins with modified o-glycosylation |
| AU2012226398B9 (en) * | 2011-03-06 | 2017-04-13 | Merck Serono S.A. | Low fucose cell lines and uses thereof |
| WO2012127045A1 (en) | 2011-03-23 | 2012-09-27 | Glycode | A yeast recombinant cell capable of producing gdp-fucose |
| DK2852610T3 (en) | 2012-05-23 | 2018-09-03 | Glykos Finland Oy | PRODUCTION OF FUCOSYLED GLYCOPROTEIN |
| TWI682033B (zh) | 2014-03-17 | 2020-01-11 | 泉盛生物科技股份有限公司 | 製造具有經修飾的糖苷化作用之重組糖蛋白之方法 |
| CA2954974A1 (en) | 2014-07-21 | 2016-01-28 | Glykos Finland Oy | Production of glycoproteins with mammalian-like n-glycans in filamentous fungi |
| EP3042952A1 (en) | 2015-01-07 | 2016-07-13 | CEVEC Pharmaceuticals GmbH | O-glycan sialylated recombinant glycoproteins and cell lines for producing the same |
| CA3019588A1 (en) | 2016-04-20 | 2017-10-26 | Merck Sharp & Dohme Corp. | Cmv neutralizing antigen binding proteins |
| EP3382014A1 (en) | 2017-03-29 | 2018-10-03 | CEVEC Pharmaceuticals GmbH | Recombinant glycoproteins with reduced antennary fucosylation |
| EP3441471A1 (en) | 2017-08-08 | 2019-02-13 | CEVEC Pharmaceuticals GmbH | Use of constitutively active variants of growth factor receptors as selection makers for the generation of stable producer cell lines |
| KR20210061341A (ko) | 2018-09-13 | 2021-05-27 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 신규한 lilrb4 항체 및 이의 용도 |
| CA3175140A1 (en) | 2020-03-12 | 2021-09-16 | Immune-Onc Therapeutics, Inc. | Novel anti-lilrb4 antibodies and derivative products |
| WO2022120064A1 (en) | 2020-12-03 | 2022-06-09 | The Board Of Regents Of The University Of Texas System | Methods for identifying lilrb-blocking antibodies |
| WO2025144785A2 (en) * | 2023-12-28 | 2025-07-03 | Dsm Ip Assets B.V. | Cells and methods for the production of glycosylated compounds |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| US5225538A (en) * | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
| WO1994023021A1 (fr) * | 1993-03-29 | 1994-10-13 | Kyowa Hakko Kogyo Co., Ltd. | α-1,3-FUCOSYLTRANSFERASE |
| US20040191256A1 (en) * | 1997-06-24 | 2004-09-30 | Genentech, Inc. | Methods and compositions for galactosylated glycoproteins |
| US20040136986A1 (en) * | 1997-10-31 | 2004-07-15 | Genentech, Inc. | Methods and compositions comprising glycoprotein glycoforms |
| JP4334141B2 (ja) * | 1998-04-20 | 2009-09-30 | グリカート バイオテクノロジー アクチェンゲゼルシャフト | 抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作 |
| US6994966B2 (en) * | 2000-02-17 | 2006-02-07 | Glycominds Ltd. | Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof |
| CA2369292C (en) * | 1999-04-09 | 2010-09-21 | Kyowa Hakko Kogyo Co. Ltd. | Method of modulating the activity of functional immune molecules |
| DE60139467D1 (de) * | 2000-05-17 | 2009-09-17 | Mitsubishi Tanabe Pharma Corp | Verfahren zur herstellung von proteinen unter reduktion von mannosephosphat in der zuckerkette und dadurch hergestelltes glykoprotein |
| US7625756B2 (en) * | 2000-06-28 | 2009-12-01 | GycoFi, Inc. | Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| KR100787073B1 (ko) | 2000-06-28 | 2007-12-21 | 글리코파이, 인크. | 변형된 당단백질의 제조방법 |
| US7863020B2 (en) * | 2000-06-28 | 2011-01-04 | Glycofi, Inc. | Production of sialylated N-glycans in lower eukaryotes |
| US7598055B2 (en) * | 2000-06-28 | 2009-10-06 | Glycofi, Inc. | N-acetylglucosaminyltransferase III expression in lower eukaryotes |
| US7449308B2 (en) * | 2000-06-28 | 2008-11-11 | Glycofi, Inc. | Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
| US7795002B2 (en) * | 2000-06-28 | 2010-09-14 | Glycofi, Inc. | Production of galactosylated glycoproteins in lower eukaryotes |
| US8697394B2 (en) * | 2000-06-28 | 2014-04-15 | Glycofi, Inc. | Production of modified glycoproteins having multiple antennary structures |
| US6946292B2 (en) * | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US20020132320A1 (en) * | 2001-01-10 | 2002-09-19 | Wang Peng George | Glycoconjugate synthesis using a pathway-engineered organism |
| CA2455365C (en) * | 2001-08-03 | 2014-07-29 | Glycart Biotechnology Ag | Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| ATE430580T1 (de) * | 2001-10-25 | 2009-05-15 | Genentech Inc | Glycoprotein-zusammensetzungen |
| US20040093621A1 (en) * | 2001-12-25 | 2004-05-13 | Kyowa Hakko Kogyo Co., Ltd | Antibody composition which specifically binds to CD20 |
| KR101001243B1 (ko) * | 2001-12-27 | 2010-12-17 | 글리코파이, 인크. | 포유동물-유형 탄수화물 구조의 설계 방법 |
| WO2003085119A1 (en) * | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO FcϜ RECEPTOR IIIa |
| PL224786B1 (pl) * | 2003-01-22 | 2017-01-31 | Glycart Biotechnology Ag | Wyizolowany kwas nukleinowy, ssaczy wektor ekspresyjny, komórki gospodarza, fuzja polipeptydowa i sposób jej wytwarzania, sposoby in vitro i ex vivo modyfikowania profilu glikozylacji polipeptydu wytwarzanego przez komórki gospodarza |
| US7332299B2 (en) * | 2003-02-20 | 2008-02-19 | Glycofi, Inc. | Endomannosidases in the modification of glycoproteins in eukaryotes |
| RU2250263C1 (ru) * | 2003-08-05 | 2005-04-20 | Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных (ФГУ ВНИИЗЖ) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК p30NE2, КОДИРУЮЩАЯ 181-АМИНОКИСЛОТНЫЙ N-КОНЦЕВОЙ ФРАГМЕНТ ГЛИКОПРОТЕИНА E2 ВИРУСА КЛАССИЧЕСКОЙ ЧУМЫ СВИНЕЙ И ОБЕСПЕЧИВАЮЩАЯ ЕГО ЭКСПРЕССИЮ В КЛЕТКАХ БАКТЕРИЙ E.coli |
| CA2548140A1 (en) * | 2003-12-05 | 2005-06-23 | University Of Massachusetts | Oligosaccharide compositions and use thereof in the treatment of infection |
| EP2341128A1 (en) * | 2003-12-24 | 2011-07-06 | GlycoFi, Inc. | Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins |
| JP4258662B2 (ja) * | 2004-04-23 | 2009-04-30 | 独立行政法人産業技術総合研究所 | O−フコース結合型タンパク質合成系遺伝子が導入された酵母形質転換体 |
| US7465577B2 (en) * | 2004-04-29 | 2008-12-16 | Glycofi, Inc. | Methods for reducing or eliminating α-mannosidase resistant glycans for the production of glycoproteins |
| KR20080021590A (ko) * | 2005-03-24 | 2008-03-07 | 네오스 테크놀로지스, 인크. | 가용성이고 활성인 진핵생물 글리코실트랜스퍼라제의원핵생물 유기체 내에서의 발현 |
-
2008
- 2008-03-03 JP JP2009552704A patent/JP2010519930A/ja active Pending
- 2008-03-03 RU RU2009136982/10A patent/RU2479629C2/ru not_active IP Right Cessation
- 2008-03-03 EP EP08726344.8A patent/EP2134834B1/en not_active Not-in-force
- 2008-03-03 US US12/528,029 patent/US20100028951A1/en not_active Abandoned
- 2008-03-03 CN CN200880014608.2A patent/CN101679934B/zh not_active Expired - Fee Related
- 2008-03-03 SG SG2013005913A patent/SG187521A1/en unknown
- 2008-03-03 CA CA002679732A patent/CA2679732A1/en not_active Abandoned
- 2008-03-03 AU AU2008227024A patent/AU2008227024A1/en not_active Abandoned
- 2008-03-03 WO PCT/US2008/002787 patent/WO2008112092A2/en not_active Ceased
- 2008-03-03 KR KR1020097020933A patent/KR20090130029A/ko not_active Ceased
-
2009
- 2009-08-18 ZA ZA200905728A patent/ZA200905728B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010519930A5 (enExample) | ||
| CN101679934B (zh) | 具有经修饰的岩藻糖基化的糖蛋白的生产 | |
| De Pourcq et al. | Engineering of glycosylation in yeast and other fungi: current state and perspectives | |
| JP4932699B2 (ja) | 真菌および酵母におけるシチジンモノホスフェート−シアル酸合成経路を操作する方法 | |
| JP2011167194A5 (enExample) | ||
| AU2004213860B2 (en) | Endomannosidases in the modification of glycoproteins in eukaryotes | |
| EP2401378B1 (en) | Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris | |
| JP5255016B2 (ja) | 改変されたn−グリカンを下等真核生物において産生するためのコンビナトリアルdnaライブラリー | |
| JP2014500019A5 (enExample) | ||
| EP1599595A2 (en) | N -acetylglucosaminyltransferase iii expression in lower eukaryotes | |
| HRP20191222T1 (hr) | Proizvodnja glikoziliranih polipeptida u mikroalgama | |
| Hamilton et al. | Progress in yeast glycosylation engineering | |
| AU2015293949A1 (en) | Production of glycoproteins with mammalian-like N-glycans in filamentous fungi | |
| CN105492620A (zh) | 具有增加的n糖基化占位的糖蛋白的生产 | |
| US20140308702A1 (en) | Yeast recombinant cell capable of producing gdp-fucose | |
| JP2009513131A (ja) | ドリコールリン酸マンノース依存α−1,3−マンノシルトランスフェラーゼをコードするハンセヌラポリモルファ起源の新規遺伝子、および前記遺伝子が欠損したハンセヌラポリモルファ変異株を用いた組み換え糖タンパク質生産方法 | |
| Clarke | Considerations for Glycoprotein Production | |
| JP2014509864A (ja) | Gdp−フコースを産生可能な酵母組換え細胞 | |
| Kim et al. | Expression and characterization of human N-acetylglucosaminyltransferases and alpha2, 3-sialyltransferase in insect cells for in vitro glycosylation of recombinant erythropoietin. |